A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment

International Journal of Neuropsychopharmacology

Volumn 14, Issue 10, 2011, Pages 1341-1355

  Gaburro, Stefano ^a,b   Stiedl, Oliver ^c   Giusti, Pietro ^b   Sartori, Simone B ^a   Landgraf, Rainer ^d   Singewald, Nicolas ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF PADOVA   (Italy)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Anxiety; autonomic system; biomarker; fear conditioning

Indexed keywords

L 822429; N [2 CYCLOPROPOXY 5 (5 TRIFLUOROMETHYL)TETRAZOL 1 YL]BENZYL 2 PHENYLPIPERIDIN 3 AMINE; NEUROKININ 1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE VARIABILITY; CONDITIONING; CONTROLLED STUDY; FEAR; FEMALE; HEART RATE VARIABILITY; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TACHYCARDIA;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR, ANIMAL; CIRCADIAN RHYTHM; CONDITIONING (PSYCHOLOGY); CUES; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY, AMBULATORY; ELECTROSHOCK; FEAR; FEMALE; HEART; HEART RATE; MICE; MOTOR ACTIVITY; NOISE; PIPERIDINES; RECEPTORS, NEUROKININ-1; ROC CURVE; TACHYCARDIA; TELEMETRY; TIME FACTORS; VIDEO RECORDING;

EID: 80054974578     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000058     Document Type: Article

References (69)

1. Agelink MW, Majewski TB, Andrich J, Mueck-WeymannM (2002). Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Critical Care Medicine 30, 997-1006. (Pubitemid 34508020)
2. Aihara M, Ida I, Yuuki N, Oshima A, et al. (2007). HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Psychiatry Research 155, 245-256. (Pubitemid 47042359)
3. APA (2000). Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision. Washington, DC: American Psychiatric Association.
4. Atack JR (2003). Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site. Current Drug Targets. CNS and Neurological Disorders 2, 213-232.
5. Bekker MH, van Mens-Verhulst J (2007). Anxiety disorders : sex differences in prevalence, degree, and background, but gender-neutral treatment. Gender Medicine 4 (SUPPL. B), S178-S193. (Pubitemid 350286526)
6. Berntson GG, Sarter M, Cacioppo JT (1998). Anxiety and cardiovascular reactivity: the basal forebrain cholinergic link. Behavioural Brain Research 94, 225-248. (Pubitemid 28352824)
7. Blanchard RJ, Blanchard DC (1969). Crouching as an index of fear. Journal of Comparative and Physiological Psychology 67, 370-375.
8. Bleil ME, Gianaros PJ, Jennings JR, Flory JD, et al. (2008 Trait negative affect : toward an integrated model of understanding psychological risk for impairment in cardiac autonomic function. Psychosomatic Medicine 70, 328-337. (Pubitemid 351543493)
9. Brunelli SA, Hofer MA (2007). Selective breeding for infant rat separation-induced ultrasonic vocalizations : developmental precursors of passive and active coping styles. Behavioural Brain Research 182, 193-207. (Pubitemid 47101913)
10. Casscells W, Vasseghi MF, Siadaty MS Madjid M, et al. (2005). Hypothermia is a bedside predictor of imminent death in patients with congestive heart failure. American Heart Journal 149, 927-933. (Pubitemid 40718895)
11. Cerutti S, Hoyer D, Voss A (2009). Multiscale, multiorgan and multivariate complexity analyses of cardiovascular regulation. Philosophical Transactions of the Royal Society, Series A: Mathematical, Physical and Engineering Sciences 367, 1337-1358.
12. Cohen H, Benjamin J (2006). Power spectrum analysis and cardiovascular morbidity in anxiety disorders. Autonomic Neuroscience : Basic & Clinical 128, 1-8. (Pubitemid 43903407)
13. Cohen H, Kaplan Z, Matar MA, Loewenthal U, et al. (2007). Long-lasting behavioral effects of juvenile trauma in an animal model of PTSD associated with a failure of the autonomic nervous system to recover. European Neuropsychopharmacology : The Journal of the European College of Neuropsychopharmacology 17, 464-477. (Pubitemid 46497658)
14. Cohen H, Kotler M, Matar M, Kaplan Z (2000). Normalization of heart rate variability in post-traumatic stress disorder patients following fluoxetine treatment : preliminary results. Israeli Medical Association Journal 2, 296-301. (Pubitemid 30662204)
15. Costoli T, Bartolomucci A, Graiani G, Stilli D, et al. (2004). Effects of chronic psychosocial stress on cardiac autonomic responsiveness and myocardial structure in mice. American Journal of Physiology. Heart and Circulatory Physiology 286, H2133-H2140. (Pubitemid 38685227)
16. Culman J, Das G, Ohlendorf C, Haass M, et al. (2010). Blockade of tachykinin NK(1)/NK(2) receptors in the brain attenuates the activation of CRH-neurones in the hypothalamic paraventricular nucleus and the sympathoadrenal and pituitary-adrenal responses to formalin-induced pain in the rat. Journal of Neuroendocrinology 22, 467-476.
17. Culman J, Klee S, Ohlendorf C, Unger T (1997). Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress. Journal of Pharmacology and Experimental Therapeutics 280, 238-246. (Pubitemid 27171408)
18. Czeh B, Fuchs E, Simon M (2006). NK1 receptor antagonists under investigation for the treatment of affective disorders. Expert Opinion on Investigational Drugs 15, 479-486.
19. Ebner K, Rupniak NM, Saria A, Singewald N (2004). Substance P in the medial amygdala: emotional stress-sensitive release and modulation of anxiety-related behavior in rats. Proceedings of the National Academy of Sciences USA 101, 4280-4285. (Pubitemid 38405920)
20. Ebner K, Sartori SB, Singewald N (2009). Tachykinin receptors as therapeutic targets in stress-related disorders. Current Pharmaceutical Design 15, 1647-1674.
21. Ebner K, Singewald GM, Whittle N, Ferraguti F, et al. (2008). Neurokinin 1 receptor antagonism promotes active stress coping via enhanced septal 5-HT transmission. Neuropsychopharmacology 33, 1929-1941. (Pubitemid 351832607)
22. Ebner K, Singewald N (2007). Stress-induced release of substance P in the locus coeruleus modulates cortical noradrenaline release. Naunyn Schmiedeberg's Archives of Pharmacology 376, 73-82.
23. Fraguas R, Marci C, Fava M, Iosifescu DV, et al. (2007). Autonomic reactivity to induced emotion as potential predictor of response to antidepressant treatment. Psychiatry Research 151, 169-172. (Pubitemid 46634630)
24. Friedman BH (2007). An autonomic flexibility-neurovisceral integration model of anxiety and cardiac vagal tone. Biological Psychology 74, 185-199. (Pubitemid 46001790)
25. Goodwin RD, Davidson KW, Keyes K (2009). Mental disorders and cardiovascular disease among adults in the United States. Journal of Psychiatric Research 43, 239-246.
26. Grippo AJ, Lamb DG, Carter CS, Porges SW (2007). Social isolation disrupts autonomic regulation of the heart and influences negative affective behaviors. Biological Psychiatry 62, 1162-1170. (Pubitemid 350030831)
27. Groenink L, van Bogaert MJ, van der Gugten J, Oosting RS, et al. (2003). 5-HT1A receptor and 5-HT1B receptor knockout mice in stress and anxiety paradigms. Behavioural Pharmacology 14, 369-383. (Pubitemid 37176796)
28. Hanley JA, McNeil BJ (1982). The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143, 29-36. (Pubitemid 12142173)
29. Harnik IG (2005). Heart-rate profile during exercise as a predictor of sudden death. New England Journal of Medicine 353, 734-735. (Pubitemid 41175685)
30. Harris JA, Westbrook RF (1998). Benzodiazepine-induced amnesia in rats : reinstatement of conditioned performance by noxious stimulation on test. Behavioral Neuroscience 112, 183-192. (Pubitemid 28106765)
31. Howden R, Liu E, Miller-DeGraff L, Keener HL, et al. (2008). The genetic contribution to heart rate and heart rate variability in quiescent mice. American Journal of Physiology. Heart and Circulatory Physiology 295, H59-H68.
32. Ikeda T, Doi M, Morita K, Ikeda K (1994). Effects of midazolam and diazepam as premedication on heart rate variability in surgical patients. British Journal of Anaesthesia 73, 479-483. (Pubitemid 24307338)
33. Johnson J, Stewart DE (2010). DSM-V: toward a gender sensitive approach to psychiatric diagnosis. Archives of Women's Mental Health 13, 17-19.
34. Knapp DJ, Pohorecky LA (1995). An air-puff stimulus method for elicitation of ultrasonic vocalizations in rats. Journal of Neuroscience Methods 62, 1-5.
35. Kramer K, Kinter LB (2003). Evaluation and applications of radiotelemetry in small laboratory animals. Physiological genomics 13, 197-205. (Pubitemid 37129185)
36. Kromer SA, Kessler MS, Milfay D, Birg IN, et al. (2005). Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. Journal of Neuroscience 25, 4375-4384. (Pubitemid 40628782)
37. Kupper NH, Willemsen G, van den Berg M, de Boer D, et al. (2004). Heritability of ambulatory heart rate variability. Circulation 110, 2792-2796.
38. Landers MS, Sullivan RM (1999). Vibrissae-evoked behavior and conditioning before functional ontogeny of the somatosensory vibrissae cortex. Journal of Neuroscience 19, 5131-5137. (Pubitemid 29270148)
39. Landgraf R, Wigger A (2002). High vs. low anxiety-related behavior rats : an animal model of extremes in trait anxiety. Behavior Genetics 32, 301-314. (Pubitemid 35192992)
40. Lavoie KL, Fleet RP, Laurin C, Arsenault A, et al. (2004). Heart rate variability in coronary artery disease patients with and without panic disorder. Psychiatry Research 128, 289-299. (Pubitemid 39490850)
41. Li P, Sur SH, Mistlberger RE, Morris M (1999). Circadian blood pressure and heart rate rhythms in mice. American Journal of Physiology 276, R500-R504. (Pubitemid 29098686)
42. Licht CM, de Geus EJ, van Dyck R, Penninx BW (2010). Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biological Psychiatry 68, 861-868.
43. Martens EJ, Nyklicek I, Szabo BM, Kupper N (2008). Depression and anxiety as predictors of heart rate variability after myocardial infarction. Psychological Medicine 38, 375-383. (Pubitemid 351311684)
44. Mayberg HS (1997). Limbic-cortical dysregulation : A proposed model of depression. Journal of Neuropsychiatry and Clinical Neurosciences 9, 471-481. (Pubitemid 27363950)
45. Meyer M, Stiedl O (2003). Self-affine fractal variability of human heartbeat interval dynamics in health and disease. European Journal of Applied Physiology 90, 305-316. (Pubitemid 37455690)
46. Montano N, Porta A, Cogliati C, Costantino G, et al. (2009). Heart rate variability explored in the frequency domain: a tool to investigate the link between heart and behavior. Neuroscience and Biobehavioral Reviews 33, 71-80.
47. Muigg P, Scheiber S, Salchner P, Bunck M, et al. (2009). Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high normal or low anxiety. PLoS One 4, e5346.
48. Mujica-Parodi LR, Korgaonkar M, Ravindranath B, Greenberg T, et al. (2009). Limbic dysregulation is associated with lowered heart rate variability and increased trait anxiety in healthy adults. Human Brain Mapping 30, 47-58.
49. Pattij T, Groenink L, Hijzen TH, Oosting RS, et al. (2002). Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice. Neuropsychopharmacology 27, 380-390. (Pubitemid 35253786)
50. Pieper SJ, Hammill SC (1995). Heart rate variability : technique and investigational applications in cardiovascular medicine. Mayo Clinic Proceedings. Mayo Clinic 70, 955-964.
51. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, et al. (2001). A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. British Medical Journal 323, 75-81. (Pubitemid 32681971)
52. Rupniak NM, Webb JK, Fisher A, Smith D, et al. (2003). The substance P (NK1) receptor antagonist L-760735 inhibits fear conditioning in gerbils. Neuropharmacology 44, 516-523. (Pubitemid 36293983)
53. Salchner P, Sartori SB, Sinner C, Wigger A, et al. (2006). Airjet and FG-7142-induced Fos expression differs in rats selectively bred for high and low anxiety-related behavior. Neuropharmacology 50, 1048-1058. (Pubitemid 43794907)
54. Sanger DJ, Joly D, Perrault G (1995). Benzodiazepine (omega) receptor partial agonists and the acquisition of conditioned fear in mice. Psychopharmacology (Berlin) 121, 104-108.
55. Sgoifo A, Stilli D, Medici D, Gallo P, et al. (1996). Electrode positioning for reliable telemetry ECG recordings during social stress in unrestrained rats. Physiology & Behavior 60, 1397-1401. (Pubitemid 26418523)
56. Shin LM, Liberzon I (2010). The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35, 169-191.
57. Singewald N, Chicchi GG, Thurner CC, Tsao KL, et al. (2008). Modulation of basal and stress-induced amygdaloid substance P release by the potent and selective NK1 receptor antagonist L-822429. Journal of Neurochemistry 106, 2476-2488.
58. Späni D, Arras M, König B, Rülicke T (2003). Higher heart rate of laboratory mice housed individually vs. in pairs. Laboratory Animals 37, 54-62.
59. Stewart SA (2005). The effects of benzodiazepines on cognition. Journal of Clinical Psychiatry 66 (SUPPL. 2), 9-13. (Pubitemid 40343675)
60. Stiedl O, Jansen RF, Pieneman AW, Ö gren SO, et al. (2009). Assessing aversive emotional states through the heart in mice: implications for cardiovascular dysregulation in affective disorders. Neuroscience and Biobehavioral Reviews 33, 181-190.
61. Stiedl O, Meyer M, Jahn O, Ö gren SO, et al. (2005). Corticotropin-releasing factor receptor 1 and central heart rate regulation in mice during expression of conditioned fear. Journal of Pharmacology and Experimental Therapeutics 312, 905-916. (Pubitemid 40293748)
62. Stiedl O, Radulovic J, Lohmann R, Birkenfeld K, et al. (1999). Strain and substrain differences in context- and tone-dependent fear conditioning of inbred mice. Behavioural Brain Research 104, 1-12. (Pubitemid 29421629)
63. Stiedl O, Spiess J (1997). Effect of tone-dependent fear conditioning on heart rate and behavior of C57BL/6N mice. Behavioral Neuroscience 111, 703-711. (Pubitemid 27335382)
64. Stiedl O, Tovote P, Ö gren SO, Meyer M (2004). Behavioral and autonomic dynamics during contextual fear conditioning in mice. Autonomic Neuroscience : Basic & Clinical 115, 15-27. (Pubitemid 39420996)
65. Tolkunov D, Rubin D, Mujica-Parodi L (2010). Power spectrum scale invariance quantifies limbic dysregulation in trait anxious adults using fMRI: adapting methods optimized for characterizing autonomic dysregulation to neural dynamic time series. Neuroimage 50, 72-80.
66. Tovote P, Meyer M, Beck-Sickinger AG, von Hörsten S, et al. (2004). Central NPY receptor-mediated alteration of heart rate dynamics in mice during expression of fear conditioned to an auditory cue. Regulatory Peptides 120, 205-214. (Pubitemid 38726209)
67. Van Bogaert MJ, Groenink L, Oosting RS, Westphal KG, et al. (2006). Mouse strain differences in autonomic responses to stress. Genes, Brain, and Behavior 5, 139-149. (Pubitemid 43348555)
68. van der Hart MG, de Biurrun G, Czeh B, Rupniak NM, et al. (2005). Chronic psychosocial stress in tree shrews: effect of the substance P (NK1 receptor) antagonist L-760735 and clomipramine on endocrine and behavioral parameters. Psychopharmacology 181, 207-216. (Pubitemid 41492190)
69. Vogelzangs N, Seldenrijk A, Beekman AT, van Hout HP, et al. (2010). Cardiovascular disease in persons with depressive and anxiety disorders. Journal of Affective Disorders 125, 241-248.